R&D expert voices

Learn more about the backgrounds, scientific pursuits and personal interests of members of our R&D team. These individuals are committed to pursuing Bristol Myers Squibb’s goal of discovering, developing and delivering transformational medicines to patients.

Ralston Barnes, PhD

Scientific Director of Transgenic Discovery, Discovery Biotherapeutics Bristol Myers Squibb

Douglas (Doug) Bassett, PhD

Senior Vice President, Informatics and Predictive Sciences

Neil Bence,  PhD

Vice President, Head of Oncology Discovery, San Diego Site Head

Miranda Broz, PhD

Scientific Director, Discovery Myeloid Biology,  Cancer Immunology and Cell Therapy

Ching-Pin (CP) Chang, MD, PhD

Vice President, Cardiovascular Discovery Biology and Translational Pharmacology

Charlotte Chapman

Head, Regional Clinical Operations Business Management, Global Development Operations

Edgar Charles, MD

Vice President, Global Program Lead, Immunology, Drug Development

Roland Chen, MD

Senior Vice President and Head of Immunology, Cardiovascular & Neuroscience Development

Sharon Cload, PhD

Vice President, Discovery Biotherapeutics, East Coast

Elizabeth (Liz) Colston, MD, PhD

Head of Immunology Clinical Development

Myrtle Davis, DVM, PhD

Executive Director, Discovery Toxicology

Justine Dell’Aringa

Senior Director, Translational Research, Cancer Immunology and Cell Therapy Thematic Research Center

Michael (Mike) Ellis, PhD

Senior Vice President, Head, Small Molecule Drug Discovery

Alison Fitch

Director, Scientific Operations and Strategy Immuno-Oncology and Cell Therapy Thematic Research Center

Teresa (Teri) Foy, PhD

Senior Vice President, Cancer Immunology and Cell Therapy Thematic Research Center
Seattle, WA


Claudia Generaux, PhD, MBA

Associate Director of Strategy and Business Development for Cardiovascular and Neuroscience

Richard Hargreaves, PhD

Senior Vice President, Neuroscience Thematic Research Center

Evan Janovitz, DVM, PhD, DAVCP

Director, Pathology, Discovery Toxicology

Alyssa Johnsen, MD, PhD

Senior Vice President, Head of Clinical Development, Immunology, Cardiovascular and Neuroscience

Ashley Koegel, MD

Executive Director, Early Clinical Development
Brisbane, CA

Debbie Law, DPhil

Senior Vice President, Head, Non-Clinical Research and Discovery Biotherapeutics 
Redwood City, California

Emma Lees, PhD

Head, Mechanisms of Cancer Resistance Thematic Research Center

Michael May, PhD

Countrywide Medical Director, Germany, Global Medical

Johan Oslob, PhD

Scientific Senior Director

Leanne Peiser, PhD

Executive Director, Immuno-Oncology and Cellular Therapy Translational Development

Michael Pourdehnad

Vice President, Head of Early Clinical Development for Hematology, Oncology and Cell Therapy

Chétna Rao, PhD

Head, Global Research & Development STEM Strategy
Bay Area, CA

Mark Rolfe, PhD

Senior Vice President, Oncogenesis Thematic Research Center
Brisbane, CA

Jonathan Sadeh, MD, MSc

Senior Vice President, Head of Global Program Leaders, Immunology, Cardiovascular and Neuroscience

Amy Sehnert, MD

Vice President, Global Program Lead for Cardiovascular Translation Assets 

Venkat Sethuraman, PhD, MBA

Senior Vice President, Global Biometrics and Data Sciences

Jinyi Zhu, PhD

Senior Principal Scientist, Protein Homeostasis Structural Biology